AzTrials
AzTrials

Type 2 DiabetesNCT02683135

Lifestyle Control of Postprandial Hyperglycemia

A study testing High-carbohydrate diet, Low-carbohydrate diet and Low-carbohydrate diet with post-meal walking in people with Type 2 Diabetes, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Large spikes in blood glucose experienced after meals in people with type 2 diabetes are known to damage blood vessels. Low carbohydrate high fat diets and exercise can improve blood glucose control in people with type 2 diabetes but it is unclear how these two strategies interact to affect blood vessel function and… Read more about this study

Who is it for?
Ages 40 to 75 years
Conditions the study is for
Type 2 Diabetes
What is being tested?
High-carbohydrate diet, Low-carbohydrate diet and Low-carbohydrate diet with post-meal walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteCanada
Study dates
Nov 2015to 1 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with type 2 diabetes (at least 6 months ago)
  • Aged 40-75
  • Engaging in 2 or less moderate-to-vigorous exercise bouts per week in the last 3 months
  • Ability to understand and communicate in English to interact with the personal trainer

Who cannot join

  • Diagnosed coronary artery disease
  • Any contraindications to exercise (e.g., musculoskeletal injury)
  • Prior history of cardio- or cerebrovascular disease or myocardial infarction
  • Hypertension that is not controlled by medication (systolic blood pressure (BP) >160 mmHg and/or diastolic BP >99 mmHg)
  • Change in diabetes medications in the previous 6 months
  • Diagnosed with peripheral neuropathy
  • Taking exogenous insulin

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of British Columbia, Okanagan.

    Kelowna, British Columbia, V1V 1V7

Other trials in Canada

About this study

Official title: Low-carbohydrate Diet, With or Without Exercise, for Improving Postprandial Glucose Control and Vascular Function in Type 2 Diabetes and Prediabetes.

Large spikes in blood glucose experienced after meals in people with type 2 diabetes are known to damage blood vessels. Low carbohydrate high fat diets and exercise can improve blood glucose control in people with type 2 diabetes but it is unclear how these two strategies interact to affect blood vessel function and inflammation. We will examine how following a short-term low carbohydrate high fat diet (4 days) with or without post-meal walking impacts markers of blood vessel function and inflammation. We will also examine how a single low carbohydrate high fat meal, with or without post-meal walking, impacts blood glucose control and blood vessel function. Findings will help determine the best lifestyle approach for improving cardiovascular health in type 2 diabetes.

Conditions
Type 2 Diabetes
Being tested
High-carbohydrate diet, Low-carbohydrate diet, Low-carbohydrate diet with post-meal walking
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-carbohydrate dietBehavioural

    Participants will engage in 4 days of high-carbohydrate low fat diet as recommended by the Canadian Diabetes Association. The macronutrients content will go as follow: 55% carbohydrate, 25% protein and 20% fat. Breakfast, lunch and dinner will be provided to the participants as part of an isoenergetic diet. Between interventions there will be at least a one-week washout, where participants are encouraged to return to their baseline dietary habits.

  • Low-carbohydrate dietBehavioural

    Participants will engage in 4 days of low-carbohydrate high-fat diet. The macronutrients content will go as follow: 10% carbohydrate, 25% protein and 65% fat. Breakfast, lunch and dinner will be provided to the participants as part of an isoenergetic diet. Between interventions there will be at least a one-week washout, where participants are encouraged to return to their baseline dietary habits.

  • Low-carbohydrate diet with post-meal walkingBehavioural

    Participants will follow the same diet as in the low-carbohydrate diet arm but also perform 15 minutes of walking beginning ~15 minutes after breakfast, lunch and dinner. Approximately 70 kcal (individualized) will be added to main meals to account for exercise energy expenditure. Between interventions there will be at least a one-week washout, where participants are encouraged to return to their baseline dietary habits.

Study groups in NCT02683135
Study groupRoleWhat they receive
High-carbohydrate dietActive comparatorNot described
Receives: Behavioral: High-carbohydrate diet
Low-carbohydrate dietExperimentalNot described
Receives: Behavioral: Low-carbohydrate diet
Low-carbohydrate diet with post-meal walkingExperimentalNot described
Receives: Behavioral: Low-carbohydrate diet; Behavioral: Low-carbohydrate diet with post-meal walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in glycemic control assessed by continuous glucose monitoring in low-carbohydrate, low-carbohydrate plus post-meal walking, and high-carbohydrate low-fat arm.

    Measured: 4-day average glucose levels assessed in each arm.

Secondary outcomes (3)
  1. Change from baseline in circulating inflammatory cytokines after 4 days of intervention.

    Measured: Fasting measurements taken on day 1 and day 5.

  2. Change from baseline in toll-like receptors 2 and 4 expression on white blood cells after 4 days of intervention.

    Measured: Fasting measurements taken on day 1 and day 5.

  3. Change from baseline in flow mediated dilation of brachial artery after 4 days of intervention.

    Measured: Fasting measurements taken on day 1 and day 5.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2016 (estimated)
  2. Study startNov 2015
  3. Primary completion1 Jun 2017
  4. Study completion1 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02683135
Sponsor's protocol ID
H1501952
Status last verified
Aug 2017
First submitted
11 Feb 2016
Last updated
3 Aug 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing High-carbohydrate diet, Low-carbohydrate diet and Low-carbohydrate diet with post-meal walking in people with Type 2 Diabetes, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in glycemic control assessed by continuous glucose monitoring in low-carbohydrate, low-carbohydrate plus post-meal walking, and high-carbohydrate low-fat arm. (time frame: 4-day average glucose levels assessed in each arm.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in